Recruit faster. Reduce costs. Do real clinical research in Brazil.

Our platform cross-references the protocol's inclusion and exclusion criteria with iHealth's longitudinal clinical database — reading structured and unstructured variables from the medical record. Primary and secondary diagnoses, current line of treatment, use of specific medications, comorbidities, biomarkers and clinical history — all extracted through NLP in medical Portuguese. Result: a qualified list of eligible candidates in minutes, with full traceability for regulatory use.

Our platform cross-references the protocol's inclusion and exclusion criteria with iHealth's longitudinal clinical database — reading structured and unstructured variables from the medical record. Primary and secondary diagnoses, current line of treatment, use of specific medications, comorbidities, biomarkers and clinical history — all extracted through NLP in medical Portuguese. Result: a qualified list of eligible candidates in minutes, with full traceability for regulatory use.

Before activating a site, understand whether the patient profile exists in your hospital base. iHealth conducts epidemiological feasibility analyses per protocol and per site — estimating the number of eligible patients, expected recruitment time, and how well the local clinical profile matches the study's criteria. Activation decisions based on real data, not projections.

Before activating a site, understand whether the patient profile exists in your hospital base. iHealth conducts epidemiological feasibility analyses per protocol and per site — estimating the number of eligible patients, expected recruitment time, and how well the local clinical profile matches the study's criteria. Activation decisions based on real data, not projections.

Identification of the sites with the highest concentration of patients matching the protocol's profile — by region, specialty, and clinical history of the population served. We prioritize sites with real longitudinal data that support confirmed eligibility, reducing activation time and increasing screening conversion rates.

Identification of the sites with the highest concentration of patients matching the protocol's profile — by region, specialty, and clinical history of the population served. We prioritize sites with real longitudinal data that support confirmed eligibility, reducing activation time and increasing screening conversion rates.

Continuous monitoring of recruitment progress and clinical outcomes throughout the study — integrated with the medical record systems of partner sites. Automatic alerts for adverse events, protocol deviations, and progress milestones. Real-time dashboards for sponsors, CROs, and clinical operations teams.

Continuous monitoring of recruitment progress and clinical outcomes throughout the study — integrated with the medical record systems of partner sites. Automatic alerts for adverse events, protocol deviations, and progress milestones. Real-time dashboards for sponsors, CROs, and clinical operations teams.

The entire evidence chain generated by iHealth is documented with full traceability — from the source data to the confirmed eligibility criterion. Support for submission to the Ethics Committee (CEP), CONEP and ANVISA, with documentation packages aligned to Brazilian and international regulatory requirements (ICH E6, FDA 21 CFR Part 11).

The entire evidence chain generated by iHealth is documented with full traceability — from the source data to the confirmed eligibility criterion. Support for submission to the Ethics Committee (CEP), CONEP and ANVISA, with documentation packages aligned to Brazilian and international regulatory requirements (ICH E6, FDA 21 CFR Part 11).